ADMN417 Assignment 2: Eli Lilly in India: Rethinking the Joint Venture Strategy Executive summary: Eli Lilly entered into a joint venture with Ranbaxy in India in 1992. A decade later both must decide whether this relationship remains mutual beneficial. Both companies have enjoyed a strong working relationship with identical value system as well as strong growth. Ranbaxy has become international and thus needs to concentrate more on generics and growth in US and UK; the joint venture with Eli
Words: 1482 - Pages: 6
Very High! AGE DISTRIBUTION (YEARS) 0-14 15-60 4% 61% 61 above RP POPULATION = 97,976,603 (July 2010 estimate) 35% AMOUNT SPENT IN PHARMACEUTICALS IN 2007 COUNTRY PHILIPPINES AMOUNT 1.97 Billion US$ (84.7 Billion PHP) MARKET SHARE (ASIA) 3.93% DEMAND FOR THE PHARMACY BUSINESS IS VERY HIGH! PHILIPPINE PHARMACEUTICAL INDUSTRY FACTBOOK 7TH EDITION 2008 AND THE FRANCHISE TALK Magazine Royalty Fee (First 3 Years)! Adheres to the GMP (Good
Words: 656 - Pages: 3
Eli Lilly in India : Rethinking the Joint Venture Strategy Pharmaceutical companies spend more than 20% of their sales on research and development (R &D). Patents for product ( for 20 years) and process were essential means by which a firm protected its proprietary knowledge and they could command higher prices for their products. Many multinational pharmaceutical firm subsidiaries in India imported drugs from their country of origin and made a huge profit. However in 1970¶s, the patents for all
Words: 603 - Pages: 3
Respected Sir/Madam, I xxxx completed Bachelors in xyz College of xyz affiliated to University, Mumbai with 50% Following this, I was involved in research and has been working as an Analyst for Plant pharmaceuticals in Quality Control Department of Alapati Pharma company. I was Kindled with an ambition of higher education that would give a desired push to my career. With a strong will to pursue my further studies in Canada, I prepared for the IELTS examination
Words: 741 - Pages: 3
1.0 Introduction 1.1 Overview of Pharmaceutical Industry In Bangladesh Pharmaceuticals industry is the heart of the healthcare sector of Bangladesh. After liberation in 1971, the industry was largely dominated by MNCs, and the country was highly import dependent. In 1982, through the formulation of national drug policy, and drug control ordinance, a defined guideline for the development of the industry was created. One of the fastest growing sectors with an annual average growth rate consistently
Words: 2034 - Pages: 9
mission & vision and Organogram Company Detail Profile Square pharmaceutical is now the most leading company in Bangladesh since 1985 and is now on its way to becoming a high performance global player. Today it has achieved a state of mind among consumers. This company has founded in 1958 and since then with hard work and dedication among employees and top management, it has reached the position where every pharmaceutical company wants to reach. Square went public in 1991 and is currently
Words: 5122 - Pages: 21
20 | 485020.22 | 500325 | RELIANCE INDUSTRIES LTD. | 926.85 | 299924.43 | 500312 | OIL AND NATURAL GAS CORPORATION LTD. | 329.90 | 282245.62 | 500875 | ITC LTD. | 351.75 | 281945.90 | 500180 | HDFC BANK LTD. | 1018.90 | 255386.81 | 500209 | INFOSYS LTD. | 2181.95 | 250590.92 | 524715 | SUN PHARMACEUTICAL INDUSTRIES LTD. | 1037.30 | 249580.69 | 533278 | COAL INDIA LTD. | 381.10 | 240716.65 | 500112 | STATE BANK OF INDIA | 291.05 | 220214.48 | 500010 | HOUSING
Words: 2074 - Pages: 9
Bangladesh’s growing pharmaceutical sector The export value of pharmaceuticals is growing at a reasonable rate every year. Exports increased from $8.2 million in 2004 to $28.3 million in 2007 and posted further gains last year. Export destinations are also increasing in number. Beginning in the 1950s, when a few multinationals and local entrepreneurs set up manufacturing facilities in the then East Pakistan, now over 200 companies produce now medicines in Bangladesh. The pharmaceutical industry in Bangladesh
Words: 686 - Pages: 3
affecting the implementation of GSK marketing strategy include possible changes in international trade regulation and competitive regulation likely to be introduced by the governments of China and India. Economic factors impacting GSK marketing strategy include high rate of economic growth in China and India. Moreover, current economic uncertainties associated with European markets might have negative implications on the marketing strategy Social factors with potential implications on GSK marketing
Words: 273 - Pages: 2
CIPLA LTD. Mahesh Bhalala Roll no-3 UNDER GUIDANCE OF DR. ANIL ANGRISH NIPER Company Discription Founded in 1935, Cipla is the second largest pharmaceutical company in India with market share of 5.4% in FY10. Company offers various drugs and healthcare products with major share in many therapeutic categories & in most dosage forms. The company has well diversified product portfolio that includes OTC products, prescription products, flavors and fragrances, pesticides, and animal products
Words: 1755 - Pages: 8
